Reproductive Life Span of U.S. Women Increasing Changes in age at both menarche and menopause, study of women followed over 6 decades shows Apr 06, 2021
Tepezza Restock Coming; Osteoporotic Fractures Broken Down by State News and commentary from the endocrinology world Apr 04, 2021
Star Surgeon Took Family Medical Leave. Then She Was Fired Courtney Stephenson, DO, whose young daughter was seriously ill, sues Atrium Health Mar 30, 2021
Triage System Gets High Marks for Ovarian Cancer Debulking Surgery Key factors predicted threefold higher risk of 90-day mortality with primary surgery Mar 26, 2021
HIPEC Combo Doubles PFS in Advanced Ovarian Cancer Cisplatin/paclitaxel boosts outcomes without increasing complications in registry study Mar 26, 2021
Combo Tx Active in Recurrent, Platinum-Resistant Ovarian Cancer Ixabepilone plus bevacizumab yielded responses in a third of patients Mar 26, 2021
Overactive Bladder Drug Gains Pediatric Indication Mirabegron approved to treat kids with neurogenic detrusor overactivity Mar 26, 2021
Sale Aimed at Saving Chicago Safety Net Hospital OK'd But activists and community leaders remain wary of rushed process Mar 24, 2021
Safety Reassurance for Major Class of Diabetes Drugs Pooled trial data show no link to breast cancer Mar 24, 2021
Little Benefit With Adjuvant Therapy for High-Risk Endometrial Cancer Chemo prevented relapse but did not improve survival, no benefit from radiotherapy Mar 23, 2021
Transgender Youth at Risk for Poorer Heart Health Association could be attributed to gender-affirming hormone therapy, researcher says Mar 23, 2021
Androgen Receptor Inhibitor Active in Endometrial Cancer SGO: Apatinib for platinum-resistant ovarian cancer, pembrolizumab for advanced vulvar cancer Mar 22, 2021
Op-Ed: Yes, Women Can Have Heart Disease Too Better research can help us understand gender differences and save lives Mar 22, 2021
Hormonal IUD Shows Promise in Early Endometrial Cancer Regression seen in 82% of women with precancerous lesions Mar 21, 2021
Small Molecule Inhibitor Shows Promise in Resistant Ovarian Cancer Responses in 37% of patients with AVB-500, higher without prior bevacizumab Mar 21, 2021
Op-Ed: Primary Care and Specialty Ping Pong Let's put an end to bureaucratic medicine and treat the patient in front of us Mar 21, 2021
Is MIS Viable for Interval Debulking in Ovarian Cancer? Retrospective study compared approach versus open surgery after neoadjuvant chemotherapy Mar 21, 2021
PARP Inhibitor Tops Chemo for Recurrent BRCA Ovarian Cancer Modest improvement in PFS with rucaparib but worse outcome for reversion mutation Mar 20, 2021
Practice-Changing Trial in Second-Line Endometrial Cancer Pembrolizumab plus lenvatinib improved median OS by nearly 7 months versus chemotherapy Mar 19, 2021
PA Abortion Bill: Burials, Death Certificates for Fetal Remains Financial and emotional burdens could reduce abortion care access, critics say Mar 18, 2021
Why Women Experience COVID and the Vaccines Differently Than Men It's chromosomal and hormonal, and maybe sociocultural too Mar 17, 2021 podcast
Time to Revisit Distant Nodal Status in Breast Cancer Curability? Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
Ethics Consult: OK to Perform 'Female Circumcision'? MD/JD Weighs In You voted, now see the results and an expert's discussion Mar 12, 2021
Abortion Opponents Make New Run at Roe v. Wade But may have to wait a few years, say opponents of new Arkansas law Mar 11, 2021
HIV, High-Risk Pregnancy and Coronavirus Outcomes support case for pregnant women to be vaccinated against COVID-19 Mar 11, 2021
Meghan Markle's Bombshell Revelation The duchess reveals mental health issues and desperate moments during pregnancy Mar 09, 2021
PD-1 Inhibitor Falls Short in Triple-Negative Breast Cancer No survival benefit with pembrolizumab vs chemotherapy in second-, third-line treatment Mar 08, 2021
New Targeted Therapies Show Promise in Cancer Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
Mammo Study: One Saves Lives, More Exams Save More Lives Risk of fatal breast cancer decreases with increasing participation in screening Mar 02, 2021
GIP/GLP-1 RA Phase III Success; USPSTF Looking for Input News and commentary from the endocrinology world Feb 28, 2021
UTIs Treated Inappropriately Everywhere Both uncalled-for drugs and prolonged treatment durations, large-scale review finds Feb 26, 2021
PTSD Post-COVID; Caplyta Seeking New Indications News and commentary from the psychiatry world Feb 24, 2021
Vaginal Pessary Viable Alternative to Surgery for Weak Pelvic Floor Majority of women continued treatment for at least 5 years Feb 24, 2021
ACOG to Ob/Gyns: Get Up to Speed on Transgender, Gender-Diverse Care Docs should become clinically/culturally competent, new guidance states Feb 19, 2021
Relugolix Combo a Winner in Uterine Fibroids Trial Medication could be a viable, long-term alternative to surgery, researcher says Feb 17, 2021
'Momnibus' Bill Gaining Ground in House Package of bills is aimed at improving maternal health and healthcare for women of color Feb 17, 2021
FDA Panel Slows the Roll for Pembrolizumab in Breast Cancer Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
Has Pembrolizumab Finally Met an Indication FDA Doesn't Like? Agency staff skeptical of data in early breast cancer Feb 08, 2021
